MergerLinks Daily Review

MergerLinks Daily Review

Welcome to MergerLinks Daily Review.?Sign up here ?to get the full round up of your daily dose of blue-chip M&A news directly to your inbox.

Suncor Energy to acquire oil sand assets from TotalEnergies for CAD6.1bn.

Deutsche B?rse to acquire Simcorp for $4.3bn.

Sanofi completed the acquisition of Provention Bio for $2.9bn

Curium, HIG compete for $2bn Cardinal Health unit. (Financial Sponsors)

Deutsche Bank seeks to win over Credit Suisse clients.

You can access today’s complete newsletter here .

Scroll down for more…

No alt text provided for this image

Suncor Energy to acquire oil sand assets from TotalEnergies for CAD6.1bn.

Suncor , an integrated energy company specialized in production of synthetic crude from oil sands, agreed to acquire oil sand assets from TotalEnergies , an energy company that produces and markets oil and biofuels, natural gas and green gases, renewables, and electricity for CAD6.1bn ($4.5bn).

"This transaction represents a major step in securing long-term bitumen supply to our Base Plant upgraders at a competitive supply cost. These are valuable oil sands assets that are a strategic fit for us and add long-term shareholder value. The acquisition also introduces flexibility and optionality into our long-range capital plan, providing us with further discretion in respect of the timing and scope of future oil sands developments," Rich Kruger, Suncor President and CEO.

Suncor is advised by J.P. 摩根 , Blake, Cassels & Graydon LLP and Paul, Weiss, Rifkind, Wharton & Garrison LLP . TotalEnergies is advised by 花旗 .

No alt text provided for this image

Deutsche B?rse to acquire Simcorp for $4.3bn.

Deutsche B?rse , a German multinational offering marketplace organizing for the trading of shares and other securities, agreed to acquire SimCorp , a Danish company providing software and services to financial institutions, for $4.3bn.

The combination of SimCorp's highly complementary business offering with Deutsche B?rse's Data & Analytics businesses will create a full-scope front-to-back investment management solutions platform. This will allow Deutsche B?rse to take even better advantage of secular industry trends and to further diversify its business mix with a growing share of recurring revenues.

Simcorp is advised by 瑞信 , Covington & Burling LLP and Kromann Reumert . Deutsche B?rse is advised by 德意志银行 , 摩根士丹利 , Cravath, Swaine & Moore LLP (led by? Aaron Gruber ?and? Bethany Pfalzgraf ), Hengeler Mueller (led by?Daniel M?ritz?and? Lucina Berger ), 年利达 and Plesner (led by? Thomas Holst Laursen ?and? Janus Jepsen ). Debt financing is provided by 摩根士丹利 .

No alt text provided for this image

Sanofi completed the acquisition of Provention Bio for $2.9bn.

Sanofi , a French multinational pharmaceutical and healthcare company, completed the acquisition of Provention Bio, a Sanofi Company , a publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes, for $2.9bn.

"The acquisition of Provention Bio builds on Sanofi's mission to deliver best- and first-in-class medicines and resonates with our purpose of chasing the miracles of science for the benefit of people. By coupling Provention Bio's transformative innovation with Sanofi's expertise, we aim to bring life-changing benefits to people at risk of developing Stage 3 type 1 diabetes. Any additional indications, approvals and pipeline assets only serve to further our excitement. Given our existing partnership and complementary work in the diabetes and immunology spaces, we foresee a seamless integration and execution," Olivier Charmeil, Sanofi Executive Vice President, General Medicines.

Provention Bio was advised by 美国银行 , Centerview Partners and Ropes & Gray LLP (led by? Suni Sreepada ?and? Thomas Danielski ). Sanofi was advised by PJT Partners and Weil, Gotshal & Manges LLP (led by? Michael J. Aiello ?and? Sachin Kohli ).

No alt text provided for this image

Curium, HIG compete for $2bn Cardinal Health unit. (FS)

Curium Pharma , a French maker of medical imaging supplies, and buyout firm H.I.G. Capital are among suitors shortlisted in the bidding for 嘉德诺 ’s nuclear medicine business.?

Cardinal has invited the remaining bidders to submit final offers by mid-May. A deal could value the business at about $2bn or more,?Bloomberg ?reported.

No alt text provided for this image

Deutsche Bank seeks to win over Credit Suisse clients.?

德意志银行 expects to pick up clients and staff from 瑞信 Group after the?Swiss lender had to be rescued by UBS Group ,?Bloomberg ?reported.

Some customers who have been doing business with both firms may be seeking to diversify following the merger of the two Swiss banks, creating opportunities in areas including wealth management, corporate banking and investment banking.

Interested to find more??Sign up here ?to get full round up of your daily dose of blue-chip M&A news directly to your inbox.

You can access today’s complete newsletter here .

要查看或添加评论,请登录

MergerLinks的更多文章

社区洞察

其他会员也浏览了